Form 4 Tracker
BECTON DICKINSON & CO
BDX

44 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 5, 2024Dec 5 9:42 PMDAVID SHAN
Proposed Sale
1,500$221.43$332.1K—

View →

Sep 16, 2024Sep 16 3:52 PMBURZIK CATHERINE M
Proposed Sale
400$235.78$94.3K—

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Aug 13, 2026Aug 14 8:36 PMThomas E Polen JrDirector, Chairman, CEO and President
Option Exercise
43,278—0(D)

View →

Aug 6, 2026Aug 6 8:47 PMRobert Luther HuffinesDirector
Grant/Award
189—595(D)

View →

Aug 6, 2026Aug 6 8:47 PMCarrie L ByingtonDirector
Grant/Award
94—3,810(D)

View →

Jun 1, 2026Jun 3 4:44 PMThomas E Polen JrDirector, Chairman, CEO and President
Option Exercise
20,209—0(D)

View →

May 8, 2026May 8 9:26 PMRobert Luther HuffinesDirector
Grant/Award
210—404(D)

View →

May 8, 2026May 8 9:25 PMCarrie L ByingtonDirector
Grant/Award
105—3,699(D)

View →

Feb 4, 2026Feb 5 5:24 PMRobert Luther HuffinesDirector
Grant/Award
100—100(D)

View →

Feb 4, 2026Feb 5 5:21 PMCarrie L ByingtonDirector
Grant/Award
30—1,714(D)

View →

Feb 4, 2026Feb 5 5:18 PMChristopher Ian Montague JonesDirector
Grant/Award
272—11,649(D)

View →

Jan 15, 2026Jan 16 8:43 PMMichael David GarrisonEVP & Pres Med.Essntl&BioPharm
Option Exercise
3,054$167.910(D)

View →